# OnCo record prostate-focal-therapy (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/prostate-focal-therapy/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "prostate-focal-therapy" ;
  schema:name "Focal and tissue-preserving treatment of prostate cancer"@en ;
  schema:alternateName "focal therapy prostate"@en, "HIFU prostate"@en, "prostate cryotherapy"@en, "partial gland ablation"@en ;
  schema:description "Treating only the part of the prostate that contains the cancer, with heat, cold or light, preserves erections and continence better than removing or irradiating the whole gland. No randomised trial has shown it controls cancer as well, and in England it is not routinely funded."@en ;
  schema:url <https://onco.cc/terms/prostate-focal-therapy/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S1470-2045(16)30661-1>, <https://doi.org/10.1016/j.urology.2023.09.004>, <https://www.nice.org.uk/guidance/ta546> ;
  onco:status "emerging" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-low-risk/>, <https://onco.cc/cancers/prostate-intermediate-risk/> ;
  onco:technologies <https://onco.cc/technologies/hifu-histotripsy/>, <https://onco.cc/technologies/cryoablation-systems/>, <https://onco.cc/technologies/brachytherapy/>, <https://onco.cc/technologies/active-surveillance/> ;
  onco:drugs <https://onco.cc/drugs/padeliporfin/> ;
  onco:terms <https://onco.cc/terms/active-surveillance-term/>, <https://onco.cc/terms/gleason-grade-group/>, <https://onco.cc/terms/qol-pro/> ;
  onco:trials <https://onco.cc/trials/nct01310894/>, <https://onco.cc/trials/protect/>, <https://onco.cc/trials/precision-mri/> .
